期刊文献+

白血病中肿瘤抑制基因p16的缺失和突变研究

STUDY OF DELETION AND MUTATION OF TUMOR SUPPRESSOR GENE p16 IN LEUKEMIA
暂未订购
导出
摘要 目的探讨肿瘤抑制基因p16在几种类型白血病中的改变及其频率。方法对77例原发性白血病及非霍奇金淋巴瘤标本分别采用Southern印迹杂交,PCR┐SSCP的方法检测缺失及点突变。结果Southernblot杂交发现p16基因异常共11例,其中纯合缺失7例,异常重组片段4例,SS┐CP发现p16第三外显子异常泳动带6例,是否为突变有待测序证实。结论p16基因改变主要集中在急性淋巴细胞性白血病,占47.7%(9/19)。 Objective:The purpose is to access the incidence of p16 gene alteration in several types of leukemias.Methods:Southern blot hybridization and PCR SSCP were used to detect deletion and mutation of p16 gene in 77 cases of hematologic malignancies respectively.Results:11 cases with p16 alteration were detected in Southern blot hybridization and 7 of them were homozygous deletion and 4 had abnormal recombinated fragement.Abnormal band migrations were detected in exon 3 and whether they are mutations or not require to be confirmed by direct sequencing analysis.Conclusion:The p16 alteration is a frequent event in leukemia and it is restricted to lymphoid neoplasm and especially to ALL. This result indicates that this tumor suppressor gene may play an important role in tumorgenesis.
出处 《肿瘤》 CAS CSCD 北大核心 1998年第6期381-384,共4页 Tumor
关键词 肿瘤抑制基因 P16基因 白血病 基因缺失 Tumor suppressor gene p16 gene Leukemia Deletion
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部